We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
1101
Supernus Pharmaceuticals
SUPN
$2.77B
$3K ﹤0.01%
99
TVTX icon
1102
Travere Therapeutics
TVTX
$5.2B
$3K ﹤0.01%
114
+18
+19% +$497
ZNTL icon
1103
Zentalis Pharmaceuticals
ZNTL
$329M
$3K ﹤0.01%
76
KLRS
1104
Kalaris Therapeutics
KLRS
$79.5M
$3K ﹤0.01%
5
IMGN
1105
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
384
AMTI
1106
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$3K ﹤0.01%
66
ENDP
1107
DELISTED
Endo International plc
ENDP
$3K ﹤0.01%
433
LMNX
1108
DELISTED
Luminex Corp
LMNX
$3K ﹤0.01%
87
FPRX
1109
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
87
PAND
1110
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$3K ﹤0.01%
56
ADVM
1111
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
18
AKRO
1112
DELISTED
Akero Therapeutics
AKRO
$2K ﹤0.01%
65
AMPH icon
1113
Amphastar Pharmaceuticals
AMPH
$888M
$2K ﹤0.01%
89
ANNX icon
1114
Annexon
ANNX
$814M
$2K ﹤0.01%
72
ARCT icon
1115
Arcturus Therapeutics
ARCT
$163M
$2K ﹤0.01%
46
ATRA icon
1116
Atara Biotherapeutics
ATRA
$70.4M
$2K ﹤0.01%
6
BDTX icon
1117
Black Diamond Therapeutics
BDTX
$101M
$2K ﹤0.01%
68
CHRS icon
1118
Coherus Oncology
CHRS
$222M
$2K ﹤0.01%
135
COLL icon
1119
Collegium Pharmaceutical
COLL
$1.16B
$2K ﹤0.01%
76
DBC icon
1120
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$2K ﹤0.01%
100
ENTA icon
1121
Enanta Pharmaceuticals
ENTA
$367M
$2K ﹤0.01%
38
GEN icon
1122
PUT
Gen Digital
GEN
$16.5B
$2K ﹤0.01%
2,444
+1,000
+69% +$21K
NBP
1123
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$2K ﹤0.01%
37
+7
+23% +$380
INVA icon
1124
Innoviva
INVA
$1.61B
$2K ﹤0.01%
191
ITOS
1125
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
66

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.